Publications
Export 63 results:
Filters: Keyword is Disease Models, Animal [Clear All Filters]
“Repetitive Traumatic Brain Injury Is Associated With TDP-43 Alterations, Neurodegeneration, and Glial Activation in Mice.”, J Neuropathol Exp Neurol, vol. 80, no. 1, pp. 2-14, 2021.
, “Platelet abnormalities in Huntington's disease.”, J Neurol Neurosurg Psychiatry, vol. 90, no. 3, pp. 272-283, 2019.
, “Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibility.”, Proc Natl Acad Sci U S A, vol. 115, no. 5, pp. 1111-1116, 2018.
, , “Establishment of a repeated social defeat stress model in female mice.”, Sci Rep, vol. 7, no. 1, p. 12838, 2017.
, “Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease.”, Neurobiol Aging, vol. 43, pp. 47-57, 2016.
, “Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease.”, FASEB J, vol. 29, no. 10, pp. 4273-84, 2015.
, “Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.”, Ann Neurol, vol. 78, no. 2, pp. 160-77, 2015.
, “Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.”, Neurobiol Dis, vol. 82, pp. 430-444, 2015.
, “Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.”, Circulation, vol. 132, no. 4, pp. 230-40, 2015.
, “Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.”, Mol Ther, vol. 22, no. 3, pp. 498-510, 2014.
, “Insulin reverses the high-fat diet-induced increase in brain Aβ and improves memory in an animal model of Alzheimer disease.”, Diabetes, vol. 63, no. 12, pp. 4291-301, 2014.
, “IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Aβ pathology.”, J Neuroinflammation, vol. 11, p. 54, 2014.
, “Overlap of food addiction and substance use disorders definitions: analysis of animal and human studies.”, Neuropharmacology, vol. 85, pp. 81-90, 2014.
, “Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.”, Int J Neuropsychopharmacol, vol. 18, no. 6, 2014.
, “Cationized IVIg as a potential substitute to IVIg for the treatment of experimental immune thrombocytopenia.”, Int Immunopharmacol, vol. 16, no. 4, pp. 409-13, 2013.
, “Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1.”, Hum Mol Genet, vol. 22, no. 19, pp. 3947-59, 2013.
, “Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival.”, Neuron, vol. 80, no. 1, pp. 80-96, 2013.
, “Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected].”, Cell Stem Cell, vol. 12, no. 4, pp. 426-39, 2013.
, “Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.”, PLoS One, vol. 7, no. 4, p. e34932, 2012.
, “Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis.”, J Neurosci, vol. 32, no. 50, pp. 18186-95, 2012.
, “Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.”, J Neuroinflammation, vol. 9, p. 234, 2012.
, “Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.”, Neuroscience, vol. 209, pp. 136-43, 2012.
, “Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.”, J Vis Exp, no. 69, 2012.
, “Real-time imaging after cerebral ischemia: model systems for visualization of inflammation and neuronal repair.”, Methods Enzymol, vol. 506, pp. 117-33, 2012.
,